grant

Proteasome Targeting for Alloreactive Plasma Cells

Organization UNIVERSITY OF PENNSYLVANIALocation PHILADELPHIA, UNITED STATESPosted 13 Jul 2020Deadline 31 Jul 2029
NIHUS FederalResearch GrantFY202520S Catalytic Proteasome20S Core Proteasome20S Proteasome20S ProteosomeATAC sequencingATAC-seqATACseqATP phosphohydrolaseATPaseAcuteAddressAdenosine TriphosphataseAlloantigenAntibodiesAntibody titer measurementAntibody-Secreting CellsApoptosisApoptosis PathwayApoptoticAssay for Transposase-Accessible Chromatin using sequencingAutoimmune StatusAutoimmunityAutomobile DrivingAutophagocytosisAutoregulationBiP geneBiP proteinBioinformaticsBlood Plasma CellBone MarrowBone Marrow Reticuloendothelial SystemBortezomibCell BodyCell Death InductionCellsCessation of lifeChaperoneChronicCytosolDataDeathDegradation PathwayDegradative PathwayDiseaseDisorderDoseDrug resistanceER stressEndoplasmic ReticulumEngraftmentErgastoplasmExposure toGRP78GRP78 geneGene Expression InhibitorGene TranscriptionGenesGeneticGenetic TranscriptionGlucose-Regulated Protein, 78-kDGraft RejectionHSPA5Heat-Shock 70-kD Protein 5HeterozygoteHomeostasisHumanImmunodeficient MouseImmunoglobulin-Secreting CellsIn VitroInduction of ApoptosisKineticsKnowledgeLifeMacropainMacroxyproteinaseMediatingMembraneMetabolic Protein DegradationMiceMice MammalsModern ManMolecular ChaperonesMovementMulticatalytic ProteinaseMurineMusNon-MalignantNon-Polyadenylated RNAOrganPathway interactionsPatientsPhysiological HomeostasisPlasma CellsPlasmacytesPlayPredispositionProgrammed Cell DeathProsomeProteasomeProteasome Endopeptidase ComplexProteasome InhibitionProteasome InhibitorProtein TraffickingProtein TurnoverProteinsProteosomeRNARNA ExpressionRNA Gene ProductsRegulatory PathwayRegulatory Protein DegradationResistanceResistance developmentResistant developmentRibonucleic AcidRoleSusceptibilityTestingTissue DonorsTranscriptionTransplant RecipientsTransplant RejectionTransplantationTransplantation RejectionUpregulationVCP/p97Workantibody titeringassay for transposase accessible chromatin followed by sequencingassay for transposase accessible chromatin seqassay for transposase accessible chromatin sequencingassay for transposase-accessible chromatin with sequencingautophagybiological adaptation to stressbody movementdesigndesigningdeveloping resistancedonor antibodiesdonor-specific antibodydrivingdrug resistantendoplasmic reticulum stressexperimentexperimental researchexperimental studyexperimentsexposed human populationgene regulatory networkgenetic inhibitorheterozygosityhuman exposureimmunoglobulin heavy chain-binding proteinimprovedimproved outcomein vivoinhibitorinsightmembrane structuremulticatalytic endopeptidase complexmultiomicsmultiple omicsnew approachesnonmalignantnovel approachesnovel strategiesnovel strategyp97-VCP proteinpanomicspathwayplasmocytepreventpreventingprogramsprotein degradationprotein homeostasisprotein transportproteostasisreaction; crisisresistance to Drugresistantresistant to DrugresponsescRNA sequencingscRNA-seqsingle cell RNA-seqsingle cell RNAseqsingle cell expression profilingsingle cell transcriptomic profilingsingle-cell RNA sequencingsocial rolestress responsestress; reactionsynergismtraffickingtransplanttransplant patientvalosin containing protein p97valosin-containing proteinvalosine-containing protein
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

Abstract
The induction of plasma cells that secrete antibodies against donor tissue alloantigens is

a major barrier to successful transplantation. Moreover, because many plasma cells are

remarkably long-lived, the resulting antibody titers are exceptionally durable. Hence

strategies are needed to eliminate long-lived plasma cells that generate…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →